Table 2 Hazard ratios for total and excess mortality in patients with nodular lymphocyte predominant Hodgkin lymphoma.
Characteristic | Total mortality | Excess mortality | ||||
|---|---|---|---|---|---|---|
HRa | 95% CIb | p-value | HRa | 95% CIb | p-value | |
Age at diagnosis (per 10-year increase) | 2.09 | 1.74−2.52 | <0.001 | 1.75 | 1.15−2.66 | 0.009 |
Sex | ||||||
Male | 1.00 | — | — | 1.00 | — | — |
Female | 0.71 | 0.42−1.22 | 0.2 | 0.89 | 0.29−2.77 | 0.8 |
Year of diagnosis (per 10-year increase) | 0.52 | 0.34−0.80 | 0.003 | 0.38 | 0.15−0.98 | 0.046 |
Transformation | ||||||
Nontransformed | 1.00 | — | — | 1.00 | — | — |
Transformed | 8.55 | 4.49−16.3 | <0.001 | 26.7 | 9.41−75.9 | <0.001 |
